{{medical}}
{{Drugbox 
| IUPAC_name        =  (+)-(6''R'',7''R'')-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
| image             = Cefdaloxime.svg 
| CAS_number_Ref        =  {{cascite|changed|??}}
| CAS_number = 80195-36-4
| ATC_prefix = 无
| ATC_suffix =  
| ATC_supplemental =  
| PubChem = 9571072
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChEMBL = 2104469
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6856HDT30F
|  ChemSpiderID = 7845538
|  smiles = O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\O)/c3nc(sc3)N)COC)C(=O)O
|  StdInChI = 1S/C14H15N5O6S2/c1-25-2-5-3-26-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-27-14(15)16-6/h4,8,12,24H,2-3H2,1H3,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1
|  StdInChIKey = HOGISBSFFHDTRM-GHXIOONMSA-N
| chemical_formula  =  
| C=14 | H=15 | N=5 | O=6 | S=2  
| molecular_weight  = 413.434 g/mol 
| smiles            = COCC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O 
| bioavailability   =  
| protein_bound     =  
| metabolism        =  
| elimination_half-life =  
| excretion         =  
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X --> 
| pregnancy_US      =  <!-- A / B            / C / D / X --> 
| pregnancy_category=   
| legal_AU =  <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> 
| legal_CA =  <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> 
| legal_UK =  <!-- GSL, P, POM, CD, or Class A, B, C --> 
| legal_US =  <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> 
| legal_status      =  
| routes_of_administration =  
}} 
'''头孢达肟'''（其[[国际非专利药品名称|国际非专利药品名称]]为“Cefdaloxime”）是一种第三代[[头孢菌素|头孢菌素]]。
{{antibiotic-stub}} 
{{细胞壁破坏性抗生素}} 
[[Category:头孢菌素|Category:头孢菌素]] 
[[Category:噻唑|Category:噻唑]] 
[[Category:肟|Category:肟]]